Is premenstrual dysphoric disorder a distinct clinical entity? - Wikidata - awgldk - TriplyDB

Is premenstrual dysphoric disorder a distinct clinical entity?

Is premenstrual dysphoric disorder a distinct clinical entity?

http://www.wikidata.org/entity/Q33934979

about

Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.Prefrontal brain asymmetry and pre-menstrual dysphoric disorder symptomatology.Menstrual cycle-related exacerbation of disease Premenstrual dysphoric disorder: evidence for a new category for DSM-5 Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects.Ethanol effects on GABA-gated current in a model of increased alpha4betadelta GABAA receptor expression depend on time course and preexposure to low concentrations of the drug.Neurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits.Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: Remission Analysis Following a Randomized, Double-Blind, Placebo-Controlled Trial Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences.Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder.Progesterone withdrawal reduces paired-pulse inhibition in rat hippocampus: dependence on GABA(A) receptor alpha4 subunit upregulation.Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.Ecological validity and clinical utility of Patient-Reported Outcomes Measurement Information System (PROMIS®) instruments for detecting premenstrual symptoms of depression, anger, and fatigue Current management of premenstrual syndrome and premenstrual dysphoric disorder.Fluoxetine in the treatment of premenstrual dysphoric disorder.Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder.How does premenstrual dysphoric disorder relate to depression and anxiety disorders?Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.Steroid requirements for regulation of the alpha4 subunit of the GABA(A) receptor in an in vitro model Personality Traits of Suicidality Are Associated with Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Suicidal Women Sample.Added benefits of drospirenone for compliance.Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.Is objective and accurate cognitive assessment across the menstrual cycle possible? A feasibility study.Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol.Premenstrual dysphoric disorder: prevalence, diagnostic considerations, and controversies.Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test.Premenstrual dysphoric disorder: burden of illness and treatment update.A new, female-specific irritability rating scale.The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: a STAR*D report.Patterns and Predictors of Premenstrual Symptoms among Females Working in a Psychiatry Hospital.Personal history of major depression may put women at risk for premenstrual dysphoric symptomatology.Premenstrual dysphoric disorder as a correlate of suicidal ideation, plans, and attempts among a nationally representative sample.Puberty, steroids and GABA(A) receptor plasticity.Depression and related disorders during the female reproductive cycle.Menstrual mood disorders are associated with blunted sympathetic reactivity to stress Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor Neurosteroid administration and withdrawal alter GABAA receptor kinetics in CA1 hippocampus of female rats.

P2860

Q24618586-B1DFC27D-A62F-4DBE-8FCA-53783B7B38E0 Q30419064-A65ACA0C-60D5-4850-A5F1-B1DDD829CBBD Q30429090-55266624-F4F3-43F3-9DFD-26F349784E80 Q30431992-75F4B719-794F-408C-889D-36B40A3627E3 Q30462752-61418993-9A34-4021-A849-CD8367BB3153 Q30481043-060B6B5F-86D4-488A-B60F-2D94086A4B46 Q30490615-8B79DFB3-9038-4A3E-832A-F9832A383170 Q30490678-E4DB53D3-56E0-42FB-8C27-93EA5629B2BB Q33750616-C8BB710C-87E5-4AB8-B42D-DDE060C3A90D Q33757204-0D291F1D-5858-47F3-909B-E2CF0CB857FA Q33880940-F25162BA-F210-4814-8CA7-F6075DDF0876 Q33919767-02613FBC-F12F-4819-83E1-0482BA387A1F Q33919806-08984160-BF02-48F4-ABCE-7651913D123E Q34100435-C998C6C8-2145-474C-A377-485192D61A28 Q34172776-23635AD9-FE1A-4050-A0FA-DB8562A7AE5F Q34437985-F549EF52-075D-42AB-9B56-AFD944624F81 Q34579655-3ECA602E-CBDB-482C-95F3-138627E66A51 Q35003765-D5782640-0EF1-4FE8-8DCF-6FA378E9FF7E Q35136793-F2DB6FC0-DA11-4514-A90E-F215C93759B7 Q35236462-C110AC9C-B770-41AE-9CF6-F300754DE22F Q35681226-A0448298-83E5-4722-83C0-A7EC135A169B Q35762148-EFC7AB3D-B763-46C8-8E7C-08ED8FC7135E Q35919515-9522BB86-DD94-4A5E-9799-0A821B6791B0 Q36276334-516AB8AA-14B1-48EB-BE5D-CB429BCB95E9 Q36345897-A56031FF-E021-4EE9-AA91-5E8F6CE959DF Q36372044-4B526350-6D67-4B94-9D1F-3BC972F3EFFC Q36642976-1C06BFDF-D491-4078-BF18-79B6210C34DC Q36709125-B27866E2-BE97-4530-9EA2-495B0D9C5ABD Q36716452-C5720DB6-97BC-4631-AF56-BB89B9B72BE2 Q36737964-0D73F0D6-5DCC-4B24-B672-BC912AA829BC Q36737967-013C50A6-B801-4C85-ABDF-66272190AF16 Q36789368-15BFB6D5-CDCF-418B-BD8B-802DBA04CCBD Q36946214-F22F2199-650E-4354-9C99-F4E1FDD24934 Q37138473-EF72B25E-32A7-42E2-A752-B2C4289E3B3B Q37173947-AE362604-FAB4-41A3-937A-CE4B0BBC2683 Q37479936-5CBFE69F-BC58-4A04-AA76-B5A108147CB2 Q37585317-4B0F89EB-084D-4161-BEAB-F65EBDB7C7D6 Q37632975-C079580E-B65A-4B8C-82AD-CB66D017A26C Q37705438-B8BD3A38-B77B-4ED2-BFC7-2E689FA69DC4 Q45261149-0C1563AD-D768-4476-92AC-F06F93F16776

P2860

Is premenstrual dysphoric disorder a distinct clinical entity?

http://www.wikidata.org/entity/Q33934979

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Is premenstrual dysphoric disorder a distinct clinical entity?

@ast

Is premenstrual dysphoric disorder a distinct clinical entity?

@en

type

label

Is premenstrual dysphoric disorder a distinct clinical entity?

@ast

Is premenstrual dysphoric disorder a distinct clinical entity?

@en

prefLabel

Is premenstrual dysphoric disorder a distinct clinical entity?

@ast

Is premenstrual dysphoric disorder a distinct clinical entity?

@en

P1433

Q33934979-AD311BE1-D7C0-4DB4-B409-ECFC3CDB4252

P1476

Q33934979-0DC69F2B-64FC-4CE1-A72F-D780FF5BE417

P2093

Q33934979-0E914969-82AC-4C06-9793-0B3049D74B8A

Q33934979-18287D74-6E37-43FF-8018-3CE5D5E970C1

Q33934979-23EBD3FF-D814-47E2-BFE6-9642D7D61838

Q33934979-262253DF-4DE9-40F4-ABCE-2040FDD3B6C1

Q33934979-3408E84E-648B-4C63-91F4-217AF9750B5C

Q33934979-389C6C65-F674-40F6-854C-F655C75AED1F

Q33934979-69FD857C-6552-4E13-9BDB-022F7BA56458

Q33934979-896A9D59-C20A-4C1B-AB28-C9C9229B1B4C

Q33934979-95C08200-1F3D-4640-9DD9-D0D9397D267C

Q33934979-CE008B76-9626-4458-94AE-BB92914EA345

P304

Q33934979-F6B73419-7763-412D-AE62-A7DAAB6B88DF

P31

Q33934979-418B8109-7E4A-4244-A4A5-D5D02DF7CAFD

P356

Q33934979-F26B48AC-953B-4AD2-9E33-5A705B10562B

P433

Q33934979-25AB94A5-9211-4494-BD03-A5EDF11FE7C3

P478

Q33934979-12708675-D63E-4757-8D7E-2CE2245BB3B3

P577

Q33934979-D28D866E-0DBA-4E68-9830-755FE39B3E60

P698

Q33934979-D694AF38-7CFB-4389-A671-F1E6A64D8A40

P356

JWH.1.1999.8.663

P1433

Journal of Women's Health and Gender-Based Medicine

P1476

Is premenstrual dysphoric disorder a distinct clinical entity?

@en

P2093

Amsterdam J

http://www.w3.org/2001/XMLSchema#string

Endicott J

http://www.w3.org/2001/XMLSchema#string

Eriksson E

http://www.w3.org/2001/XMLSchema#string

Frank E

http://www.w3.org/2001/XMLSchema#string

Freeman E

http://www.w3.org/2001/XMLSchema#string

Hirschfeld R

http://www.w3.org/2001/XMLSchema#string

Ling F

http://www.w3.org/2001/XMLSchema#string

Parry B

http://www.w3.org/2001/XMLSchema#string

Pearlstein T

http://www.w3.org/2001/XMLSchema#string

Rosenbaum J

http://www.w3.org/2001/XMLSchema#string

P304

663-679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JWH.1.1999.8.663

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10839653

http://www.w3.org/2001/XMLSchema#string